{"transactions":[{"id":3553595,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":158294,"kind":"person","name":"Dougherty Donald","position":1,"cik":"0001709592","reported_name":"Dougherty Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-17T22:44:47.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 15, 2019. The shares underlying the option are scheduled to vest in equal monthly installments over four years from April 15, 2019."}],"balance_after":150000,"derivative":{"exercise_price":1.75,"expiration_date":"2029-04-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-19-010818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924319010818/doc4.xml","form_type":"4"}},{"id":3896696,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":158294,"kind":"person","name":"Dougherty Donald","position":1,"cik":"0001709592","reported_name":"Dougherty Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-12T21:31:02.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":3000,"price":5.4,"value":16200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.39 to $5.40 per share. The reporting person undertakes to provide Aileron Therapeutics, Inc., any security holder of Aileron Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-18-016218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924318016218/doc4.xml","form_type":"4"}},{"id":3908202,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":158294,"kind":"person","name":"Dougherty Donald","position":1,"cik":"0001709592","reported_name":"Dougherty Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-04T20:54:38.000Z","date":"2018-06-01","kind":"purchase","acquired":true,"shares":2000,"price":5.24,"value":10480.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000899243-18-014929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924318014929/doc4.xml","form_type":"4"}},{"id":4250005,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":158294,"kind":"person","name":"Dougherty Donald","position":1,"cik":"0001709592","reported_name":"Dougherty Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T22:34:51.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":60331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 25, 2017.  The shares underlying the option are scheduled to vest in equal monthly installments over four years from July 25, 2017."}],"balance_after":60331,"derivative":{"exercise_price":13,"expiration_date":"2027-07-24","underlying":"Common Stock","underlying_shares":60331},"source":{"system":"sec-edgar","filing":"0000899243-17-019219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317019219/doc4.xml","form_type":"4"}},{"id":4269167,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":158294,"kind":"person","name":"Dougherty Donald","position":1,"cik":"0001709592","reported_name":"Dougherty Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T17:32:46.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":140887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on June 28, 2017 and vest as to 25% of the shares on June 8, 2018 and vest thereafter as to 2.0833% of the shares in equal monthly installments through June 8, 2021."}],"balance_after":140887,"derivative":{"exercise_price":15,"expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":140887},"source":{"system":"sec-edgar","filing":"0000899243-17-017605","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017605/doc4.xml","form_type":"4"}}]}